Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FONDAPARINUX vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FONDAPARINUX vs RIVAROXABAN: Safety Overview

Metric FONDAPARINUX RIVAROXABAN
Total FAERS Reports 2,230 131,274
Deaths Reported 308 19,233
Death Rate 13.8% 14.7%
Hospitalizations 1,141 70,513
Average Patient Age 63.2 yrs 70.0 yrs
% Female Patients 56.5% 47.7%
FDA Approval Date Aug 19, 2024 Apr 10, 2025
Manufacturer Dr. Reddy's Laboratories Limited Macleods Pharmaceuticals Limited
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription